We are live on
!
Find out more
RWA
River Wealth Advisors Portfolio holdings
AUM
$871M
1-Year Est. Return
20.5%
This Fund
S&P 500
This Quarter
Est. Return
+12.1%
1 Year Est. Return
+20.5%
3 Year Est. Return
+67.69%
5 Year Est. Return
+75.73%
10 Year Est. Return
+267.83%
AUM
$626M
AUM Growth
+$67.2M
(+12%)
Cap. Flow
+$3.2M
Cap. Flow
% of AUM
0.51%
Top 10 Holdings %
Top 10 Hldgs %
36.24%
Holding
217
New
17
Increased
62
Reduced
121
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$3.13M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.24M |
| 3 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$1.24M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$1.21M |
| 5 |
NVIDIA
NVDA
|
+$1.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$1.08M |
| 2 |
Pfizer
PFE
|
+$941K |
| 3 |
Qualcomm
QCOM
|
+$870K |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$614K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$610K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Financials | 10.84% |
| 3 | Healthcare | 8.94% |
| 4 | Industrials | 7.36% |
| 5 | Consumer Discretionary | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Charles River Laboratories
CRL
$11.6B
| $206K | 0.03% |
+872
| New | +$171K |
|
202
RPM International
RPM
$14.2B
| $206K | 0.03% |
1,844
-280
| -13% | -$28.3K |
|
203
iShares Russell 2000 Growth ETF
IWO
$14.4B
| $204K | 0.03% |
+807
| New | +$182K |
|
204
Medtronic
MDT
$111B
| $202K | 0.03% |
+2,447
| New | +$186K |
|
205
Ocular Therapeutix
OCUL
$1.86B
| $44.6K | 0.01% |
+10,000
| New | +$29.6K |
|
206
Geron
GERN
$930M
| $21.1K | ﹤0.01% |
10,000
| – | – |
|
207
Becton Dickinson
BDX
$45.7B
| – | – |
-1,012
| Closed | -$262K |
|
208
Citigroup
C
$222B
| – | – |
-6,425
| Closed | -$264K |
|
209
Exelon
EXC
$48.5B
| – | – |
-7,815
| Closed | -$295K |
|
210
Ford
F
$59.6B
| – | – |
-14,119
| Closed | -$175K |
|
|
211
Nike
NKE
$63.8B
| – | – |
-11,293
| Closed | -$1.08M |
|
212
Opko Health
OPK
$1.25B
| – | – |
-23,500
| Closed | -$37.6K |
|
|
213
Pfizer
PFE
$144B
| – | – |
-28,382
| Closed | -$941K |
|
214
Steel Dynamics
STLD
$37.5B
| – | – |
-2,269
| Closed | -$243K |
|
215
Toronto Dominion Bank
TD
$199B
| – | – |
-5,783
| Closed | -$348K |
|
216
Target
TGT
$65.5B
| – | – |
-3,330
| Closed | -$368K |
|
Similar funds
WCM
PLFA
BFA
F1I
CWM
SA
HDIM
GCM
River Wealth Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, River Wealth Advisors held 217 positions worth $626M, up 12% from $559M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
River Wealth Advisors's Q4 2023 filing shows 17 new, 62 increased, 121 reduced and 10 closed positions. Its largest new stake was Vanguard Russell 1000 Growth ETF: 17,076 shares worth $1.33M. The largest sale was Nike, an estimated $1.08M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- River Wealth Advisors's largest Q4 2023 buy was Vanguard Russell 1000 Growth ETF: 17,076 shares worth $1.33M.
- River Wealth Advisors added most to iShares Russell 2000 ETF in Q4 2023, an estimated $3.13M increase.
- River Wealth Advisors's biggest Q4 2023 reduction was Qualcomm, cutting an estimated $870K.
- River Wealth Advisors fully exited Nike in Q4 2023, selling an estimated $1.08M.
- River Wealth Advisors's ten largest holdings make up 36% of its $626M portfolio in Q4 2023.
- River Wealth Advisors opened 17 new positions and closed 10 in Q4 2023.
- River Wealth Advisors's portfolio value rose 12% quarter-over-quarter to $626M.
Based on River Wealth Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.